ilab provides a supportive environment for University of Queensland entrepreneurs. such as students, researchers and alumni. by mentoring them through the early stage of business development and providing seed funding to scale their business.
Want to inform investors similar to i.lab about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest i.lab News
Aug 29, 2017
August 29, 2017 04:06 PM Eastern Daylight Time RICHMOND, Va.--( BUSINESS WIRE )--Virginia Bio, the premier statewide non-profit association of the life science industry in Virginia, elected Andrew J. Krouse to a two-year term as Chairman of the Board of Directors, during the annual meeting of the Board held at i.Lab at UVA . Andrew Krouse, MALS, is the President & CEO of Cavion, Inc. , a venture-backed pharmaceutical company in Charlottesville, developing best-in-class T-type calcium channel (Cav3) therapies that restore the brain’s natural rhythms and normal function in diseases that share a common pathophysiology, including movement disorders, epilepsy, and pain. Mr. Krouse has over a decade of biotech leadership experience as founder of Tau Therapeutics LLC, Xdynia LLC and Cavion, Inc. Mr. Krouse has served as a member of the Virginia Bio Board of Directors since 2011, most recently as Vice-Chairman. “I look forward to working with my colleagues throughout industry and academia to keep this great organization going strong," said Mr. Krouse. “My priorities will be to increase access of Virginia companies to private investment, engender a richer active engagement of all of our members in our community, and better communicate the story of Virginia bioscience commercialization to policy makers and other stakeholders.” Alan Connor, President & CEO of Cadence Inc. , Staunton, was elected as Vice-Chairman. Cadence Inc. is a full-service contract manufacturer and leading supplier of advanced products, technologies and services to medical device, life science, and industrial companies worldwide. Ross Dunlap, CEO and a co-founder of Ceres Nanosciences , Prince William County, was elected Secretary. Among other things, Mr. Dunlap is directing the clinical development, validation, and market launch of a novel Lyme Antigen Test that will provide the most sensitive and accurate detection of Lyme disease. The board also elected as a new Director Eric Paradise, who is a Senior Director in business development at MedImmune , the global biologics R&D arm of AstraZeneca. Other officers and members of the Executive Committee of Virginia Bio Board are Crystal Icenhour, CEO Aperiomics , Ashburn, Immediate Past Chair; Jeff Conroy, CEO Embody LLC , Norfolk, Past Chair; Carrie Roth, CEO VA Bio+Tech Park , Richmond, Treasurer; and Jim Powers, CEO HemoShear , Charlottesville. The complete list of Virginia Bio board members is at http://www.vabio.org/?leadership . About Virginia Bio Virginia Bio is the premier statewide non-profit trade association for life sciences, promoting the considerable scientific and economic impact of the life sciences industry in the Commonwealth of Virginia. Virginia Bio is an advocate for innovation and entrepreneurship, and for the biopharmaceutical, and other health technology industries among federal, state and local policy-makers. Virginia Bio is the official state affiliate of BIO (the Biotechnology Innovation Organization), AdvaMed and MDMA (Medical Device Manufacturers Association), and works closely with PhRMA (Pharmaceutical Research and Manufacturers of America). To learn more, visit www.vabio.org or follow Virginia Bio on Twitter at @VABio Contacts
i.lab has made 25 investments. Their latest investment was in Rise 4 REAL Change as part of their Incubator/Accelerator on June 6, 2017.
i.lab Investments Activity
Rise 4 REAL Change
1 Team Member
i.lab has 1 team member, including former Chief Executive Officer, Anne Marie Birkill.
Compare i.lab to Competitors
Cambridge Innovation Center (CIC) specializes in building and operating campuses that support the growth of entrepreneurs and startups. Its collaborative work environments support individuals in the for-profit and nonprofit sectors who are focused on solutions to local and global problems. It was founded in 1999 and is based in Cambridge, Massachusetts.
Hall Labs brings together all the resources needed to grow a new technology concept from start to finish. Every critical piece of the business development process is covered in the Hall Labs system, all on one campus. The companies grown in Hall Labs have access to funding, research and devlopment, machine learning, engineering, supply chains, patent support, and more. A vast team of unified engineers, chemists, strategists, accountants, attorneys, advisors, and other professionals support the projects.
Ufi Ventures offers early-stage ventures finance and support that draws on the depth of Ufi’s experience in developing digital technologies.
Collaborative Drug Discovery, Inc. (CDD) is the world's first platform for selectively sharing collaborative drug discovery data. Scientists working with the CDD community platform can pool their research in order to more effectively develop new drug candidates for commercial and humanitarian markets. CDD is based in Burlingame, California (15 miles south of San Francisco). The company provides software and custom services to academic, foundation, and corporate clients since 2004. The CDD global community includes hundreds of scientists from leading research foundations, academia and industry. A subset of the data is available openly to the public at no cost. It was founded in 2004 and is based in Burlingame, California.
LabFellows is a digital research platform and full service lab concierge supporting BioTech companies through the discover and development phase. By leveraging sharing economy principles, deep understanding of scientific research, and the technology platform, LabFellows is able to save BioTech companies money on their capital expenditures while accelerating their research timelines. LabFellows is a research support ecosystem dedicated to fostering innovation. With LabFellows, scientists have access to configurable lab spaces and a large, growing network of partner facilities that can support almost any workflow. Researchers have access to fully functioning labs, veteran scientists and digital research testing.
College Street Innovation Fund (CSIF) offers seed funding to student-led Yale startups. College Street Innovation Fund supports student-founded and student/faculty co-founded ventures. It is based in New Haven, Connecticut.